US Stock MarketDetailed Quotes

LUMO Lumos Pharma

Watchlist
  • 1.760
  • -0.040-2.22%
Close Jul 29 16:00 ET
14.29MMarket Cap-384P/E (TTM)

Lumos Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-76.12%165K
34.67%2.05M
61.33%826K
-98.59%7K
136.96%1.22M
522.52%691K
562.17%1.52M
132.73%512K
497K
5,040.00%514K
Operating revenue
-76.12%165K
34.67%2.05M
61.33%826K
-98.59%7K
136.96%1.22M
522.52%691K
562.17%1.52M
132.73%512K
--497K
5,040.00%514K
Cost of revenue
Gross profit
Operating expense
26.37%11.03M
15.20%38.67M
15.87%10.83M
11.08%8.94M
16.87%18.9M
11.27%8.73M
6.29%33.56M
37.68%9.35M
7.34%8.05M
86.41%16.17M
Selling and administrative expenses
-13.27%3.78M
5.49%16.57M
-6.96%4.17M
-0.64%3.89M
16.43%8.5M
20.33%4.36M
2.45%15.71M
30.83%4.49M
15.75%3.92M
60.12%7.3M
-General and administrative expense
-13.27%3.78M
5.49%16.57M
-6.96%4.17M
-0.64%3.89M
16.43%8.5M
20.33%4.36M
2.45%15.71M
30.83%4.49M
15.75%3.92M
60.12%7.3M
Research and development costs
65.90%7.25M
23.74%22.1M
36.92%6.66M
22.21%5.05M
17.22%10.39M
3.51%4.37M
9.92%17.86M
44.66%4.86M
0.41%4.13M
115.56%8.87M
Operating profit
-35.18%-10.86M
-14.28%-36.61M
-13.23%-10M
-18.30%-8.93M
-12.92%-17.68M
-3.93%-8.04M
-2.21%-32.04M
-34.50%-8.84M
-0.71%-7.55M
-80.69%-15.66M
Net non-operating interest income expense
-72.28%158K
113.73%1.87M
-41.75%293K
52.74%446K
1,329.11%1.13M
11,300.00%570K
7,183.33%874K
1,097.62%503K
14,500.00%292K
3,850.00%79K
Non-operating interest income
-72.28%158K
113.73%1.87M
-41.75%293K
52.74%446K
1,329.11%1.13M
11,300.00%570K
7,183.33%874K
9,960.00%503K
14,500.00%292K
3,850.00%79K
Other net income (expense)
121.01%263K
650.55%683K
252.78%254K
2,557.14%186K
1,925.00%243K
1,883.33%119K
-66.17%91K
-71.20%72K
0.00%7K
250.00%12K
Other non- operating income (expenses)
121.01%263K
650.55%683K
252.78%254K
2,557.14%186K
1,925.00%243K
1,883.33%119K
-66.17%91K
-71.20%72K
0.00%7K
250.00%12K
Income before tax
-42.13%-10.44M
-9.62%-34.06M
-14.49%-9.46M
-14.47%-8.3M
-4.77%-16.31M
4.84%-7.35M
-0.03%-31.08M
-31.59%-8.26M
3.17%-7.25M
-79.52%-15.56M
Income tax
-123.08%-29K
0
0
-29K
97.96%-13K
-13K
0
0
Net income
-42.13%-10.44M
-9.57%-34.03M
-14.67%-9.46M
-14.47%-8.3M
-4.58%-16.28M
4.84%-7.35M
-2.08%-31.06M
-46.20%-8.25M
3.17%-7.25M
-79.52%-15.56M
Net income continuous Operations
-42.13%-10.44M
-9.57%-34.03M
-14.67%-9.46M
-14.47%-8.3M
-4.58%-16.28M
4.84%-7.35M
-2.08%-31.06M
-46.20%-8.25M
3.17%-7.25M
-79.52%-15.56M
Minority interest income
Net income attributable to the parent company
-42.13%-10.44M
-9.57%-34.03M
-14.67%-9.46M
-14.47%-8.3M
-4.58%-16.28M
4.84%-7.35M
-2.08%-31.06M
-46.20%-8.25M
3.17%-7.25M
-79.52%-15.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-42.13%-10.44M
-9.57%-34.03M
-14.67%-9.46M
-14.47%-8.3M
-4.58%-16.28M
4.84%-7.35M
-2.08%-31.06M
-46.20%-8.25M
3.17%-7.25M
-79.52%-15.56M
Basic earnings per share
-44.94%-1.29
-12.67%-4.18
-19.39%-1.17
-20.93%-1.04
-6.45%-1.98
3.26%-0.89
-1.64%-3.71
-44.12%-0.98
4.44%-0.86
-87.88%-1.86
Diluted earnings per share
-44.94%-1.29
-12.67%-4.18
-19.39%-1.17
-20.93%-1.04
-6.45%-1.98
3.26%-0.89
-1.64%-3.71
-44.12%-0.98
4.44%-0.86
-87.88%-1.86
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -76.12%165K34.67%2.05M61.33%826K-98.59%7K136.96%1.22M522.52%691K562.17%1.52M132.73%512K497K5,040.00%514K
Operating revenue -76.12%165K34.67%2.05M61.33%826K-98.59%7K136.96%1.22M522.52%691K562.17%1.52M132.73%512K--497K5,040.00%514K
Cost of revenue
Gross profit
Operating expense 26.37%11.03M15.20%38.67M15.87%10.83M11.08%8.94M16.87%18.9M11.27%8.73M6.29%33.56M37.68%9.35M7.34%8.05M86.41%16.17M
Selling and administrative expenses -13.27%3.78M5.49%16.57M-6.96%4.17M-0.64%3.89M16.43%8.5M20.33%4.36M2.45%15.71M30.83%4.49M15.75%3.92M60.12%7.3M
-General and administrative expense -13.27%3.78M5.49%16.57M-6.96%4.17M-0.64%3.89M16.43%8.5M20.33%4.36M2.45%15.71M30.83%4.49M15.75%3.92M60.12%7.3M
Research and development costs 65.90%7.25M23.74%22.1M36.92%6.66M22.21%5.05M17.22%10.39M3.51%4.37M9.92%17.86M44.66%4.86M0.41%4.13M115.56%8.87M
Operating profit -35.18%-10.86M-14.28%-36.61M-13.23%-10M-18.30%-8.93M-12.92%-17.68M-3.93%-8.04M-2.21%-32.04M-34.50%-8.84M-0.71%-7.55M-80.69%-15.66M
Net non-operating interest income expense -72.28%158K113.73%1.87M-41.75%293K52.74%446K1,329.11%1.13M11,300.00%570K7,183.33%874K1,097.62%503K14,500.00%292K3,850.00%79K
Non-operating interest income -72.28%158K113.73%1.87M-41.75%293K52.74%446K1,329.11%1.13M11,300.00%570K7,183.33%874K9,960.00%503K14,500.00%292K3,850.00%79K
Other net income (expense) 121.01%263K650.55%683K252.78%254K2,557.14%186K1,925.00%243K1,883.33%119K-66.17%91K-71.20%72K0.00%7K250.00%12K
Other non- operating income (expenses) 121.01%263K650.55%683K252.78%254K2,557.14%186K1,925.00%243K1,883.33%119K-66.17%91K-71.20%72K0.00%7K250.00%12K
Income before tax -42.13%-10.44M-9.62%-34.06M-14.49%-9.46M-14.47%-8.3M-4.77%-16.31M4.84%-7.35M-0.03%-31.08M-31.59%-8.26M3.17%-7.25M-79.52%-15.56M
Income tax -123.08%-29K00-29K97.96%-13K-13K00
Net income -42.13%-10.44M-9.57%-34.03M-14.67%-9.46M-14.47%-8.3M-4.58%-16.28M4.84%-7.35M-2.08%-31.06M-46.20%-8.25M3.17%-7.25M-79.52%-15.56M
Net income continuous Operations -42.13%-10.44M-9.57%-34.03M-14.67%-9.46M-14.47%-8.3M-4.58%-16.28M4.84%-7.35M-2.08%-31.06M-46.20%-8.25M3.17%-7.25M-79.52%-15.56M
Minority interest income
Net income attributable to the parent company -42.13%-10.44M-9.57%-34.03M-14.67%-9.46M-14.47%-8.3M-4.58%-16.28M4.84%-7.35M-2.08%-31.06M-46.20%-8.25M3.17%-7.25M-79.52%-15.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -42.13%-10.44M-9.57%-34.03M-14.67%-9.46M-14.47%-8.3M-4.58%-16.28M4.84%-7.35M-2.08%-31.06M-46.20%-8.25M3.17%-7.25M-79.52%-15.56M
Basic earnings per share -44.94%-1.29-12.67%-4.18-19.39%-1.17-20.93%-1.04-6.45%-1.983.26%-0.89-1.64%-3.71-44.12%-0.984.44%-0.86-87.88%-1.86
Diluted earnings per share -44.94%-1.29-12.67%-4.18-19.39%-1.17-20.93%-1.04-6.45%-1.983.26%-0.89-1.64%-3.71-44.12%-0.984.44%-0.86-87.88%-1.86
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-9.06%